Meddo Health partners with ICMR approved labs to launch rapid test kits by next week
Meddo, India's largest out-patient care network in partnership with Indian Council of Medical Research (ICMR) approved labs has started booking for COVID-19 (RT-PCR) testing in Delhi NCR
COVID 19 And Pharma Companies | 06/04/2020 | By Darshana | 353
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
As part of the Trump Administration's all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments
COVID 19 And Pharma Companies | 01/04/2020 | By Darshana | 430
The COVID-19 pandemic is straining health systems worldwide. The rapidly increasing demand on health facilities and health care workers threatens to leave some health systems overstretched and unable to operate effectively
COVID 19 And Pharma Companies | 01/04/2020 | By Darshana | 558
FDA expedites review of diagnostic tests to combat COVID-19
The U.S. Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S. The FDA's regulations have not hindered or been a roadblock to the rollout of tests during this pandemic
COVID 19 And Pharma Companies | 31/03/2020 | By Darshana | 367
Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes
COVID 19 And Pharma Companies | 30/03/2020 | By Darshana | 399
Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. The industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions
COVID 19 And Pharma Companies | 28/03/2020 | By Darshana | 447
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy